Histone deacetylase 2 (HDAC2) attenuates lipopolysaccharide (LPS)-induced inflammation by regulating PAI-1 expression

[1]  Min Zhang,et al.  HDAC2 Suppresses IL17A‐Mediated Airway Remodeling in Human and Experimental Modeling of COPD , 2017, Chest.

[2]  I. Douglas,et al.  Development and validation of immune dysfunction score to predict 28-day mortality of sepsis patients , 2017, PloS one.

[3]  Ya-Ting Chang,et al.  Immune profiles and clinical outcomes between sepsis patients with or without active cancer requiring admission to intensive care units , 2017, PloS one.

[4]  Honglin Luo,et al.  Long-term cigarette smoke exposure inhibits histone deacetylase 2 expression and enhances the nuclear factor-κB activation in skeletal muscle of mice , 2017, Oncotarget.

[5]  T. Miyata,et al.  Plasminogen activator inhibitor‐1 regulates macrophage‐dependent postoperative adhesion by enhancing EGF‐HER1 signaling in mice , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  J. Cleveland,et al.  Ornithine decarboxylase regulates M1 macrophage activation and mucosal inflammation via histone modifications , 2017, Proceedings of the National Academy of Sciences.

[7]  Fuqiang Wen,et al.  Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease , 2016, International journal of chronic obstructive pulmonary disease.

[8]  F. Castellino,et al.  Plasminogen activator inhibitor-1 stimulates macrophage activation through Toll-like Receptor-4. , 2016, Biochemical and biophysical research communications.

[9]  P. Flevaris,et al.  The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis , 2016, Seminars in Thrombosis and Hemostasis.

[10]  T. Miyata,et al.  Novel Plasminogen Activator Inhibitor-1 Inhibitors Prevent Diabetic Kidney Injury in a Mouse Model , 2016, PloS one.

[11]  M. Weigand,et al.  Why a second look might be worth it: immuno-modulatory therapies in the critically ill patient. , 2016, Journal of thoracic disease.

[12]  T. Reinheckel,et al.  Neutrophil and Alveolar Macrophage-Mediated Innate Immune Control of Legionella pneumophila Lung Infection via TNF and ROS , 2016, PLoS pathogens.

[13]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[14]  G. Erten,et al.  PAI-1 and TNF-α profiles of adipose tissue in obese cardiovascular disease patients. , 2015, International journal of clinical and experimental pathology.

[15]  A. Morice,et al.  Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial , 2015, Trials.

[16]  S. Mashiko,et al.  Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer , 2015, Cancer biology & therapy.

[17]  I. Douglas,et al.  5-Lipoxygenase Activating Protein (FLAP) Dependent Leukotriene Biosynthesis Inhibition (MK591) Attenuates Lipid A Endotoxin-Induced Inflammation , 2014, PloS one.

[18]  Lijuan Hu,et al.  Plasminogen Activator Inhibitor-1 Regulates LPS Induced Inflammation in Rat Macrophages through Autophagy Activation , 2014, TheScientificWorldJournal.

[19]  Hua He,et al.  Lipopolysaccharide Induces Up-Regulation of TGF-α through HDAC2 in a Rat Model of Bronchopulmonary Dysplasia , 2014, PloS one.

[20]  J. Sheu,et al.  Histone Deacetylase Inhibitor Impairs Plasminogen Activator Inhibitor-1 Expression via Inhibiting TNF-α-Activated MAPK/AP-1 Signaling Cascade , 2014, BioMed research international.

[21]  M. Schuliga,et al.  The plasminogen activation system: new targets in lung inflammation and remodeling. , 2013, Current opinion in pharmacology.

[22]  T. Miyata,et al.  A Small Molecule Inhibitor to Plasminogen Activator Inhibitor 1 Inhibits Macrophage Migration , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[23]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 , 2013, Intensive Care Medicine.

[24]  M. Dalboni,et al.  TNF-α modulates statin effects on secretion and expression of MCP-1, PAI-1 and adiponectin in 3T3-L1 differentiated adipocytes. , 2012, Cytokine.

[25]  Cheng Cheng Tan,et al.  Management of severe sepsis in patients admitted to Asian intensive care units: prospective cohort study , 2011, BMJ : British Medical Journal.

[26]  C. Dinarello,et al.  Histone Deacetylase Inhibitors for Treating a Spectrum of Diseases Not Related to Cancer , 2011, Molecular medicine.

[27]  M. Cesari,et al.  Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. , 2010, Cardiovascular therapeutics.

[28]  Kyung-Hee Lee,et al.  Inhibition of histone deacetylase activity down-regulates urokinase plasminogen activator and matrix metalloproteinase-9 expression in gastric cancer , 2010, Molecular and Cellular Biochemistry.

[29]  T. Miyata,et al.  A Novel Inhibitor of Plasminogen Activator Inhibitor-1 Provides Antithrombotic Benefits Devoid of Bleeding Effect in Nonhuman Primates , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  Richard Beale,et al.  The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis , 2010, Intensive Care Medicine.

[31]  I. Autenrieth,et al.  Forced IFIT-2 expression represses LPS induced TNF-alpha expression at posttranscriptional levels , 2008, BMC Immunology.

[32]  Jee Sun Yang,et al.  Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model , 2008, Experimental & Molecular Medicine.

[33]  Young-Jin Kim,et al.  Regulation of macrophage inflammatory protein-2 gene expression in response to 2,4-dinitrofluorobenzene in RAW 264.7 cells. , 2008, BMB Reports.

[34]  I. Douglas,et al.  Lipid A fraction of LPS induces a discrete MAPK activation in acute lung injury. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[35]  M. Hyman,et al.  Molecular regulation of the PAI‐1 gene by hypoxia: contributions of Egr‐1, HIF‐1 α, and C/EBPα , 2007 .

[36]  E. Abraham,et al.  Involvement of the Urokinase Kringle Domain in Lipopolysaccharide-Induced Acute Lung Injury1 , 2006, The Journal of Immunology.

[37]  I. Rahman,et al.  Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[38]  E. Abraham,et al.  Plasminogen activator inhibitor-1 potentiates LPS-induced neutrophil activation through a JNK–mediated pathway , 2006, Thrombosis and Haemostasis.

[39]  I. Adcock,et al.  Decreased histone deacetylase activity in chronic obstructive pulmonary disease. , 2005, The New England journal of medicine.

[40]  T. Iba,et al.  ASSOCIATION BETWEEN THE SEVERITY OF SEPSIS AND THE CHANGES IN HEMOSTATIC MOLECULAR MARKERS AND VASCULAR ENDOTHELIAL DAMAGE MARKERS , 2005, Shock.

[41]  N. Thomson,et al.  Asthma and cigarette smoking , 2004, European Respiratory Journal.

[42]  I. Adcock,et al.  Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages , 2004, The Journal of experimental medicine.

[43]  I. Adcock,et al.  Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase , 2004, The Lancet.

[44]  P. Andreasen,et al.  Plasminogen activator inhibitor-1 and tumour growth, invasion, and metastasis , 2004, Thrombosis and Haemostasis.

[45]  J. Han,et al.  NF-κB and c-Jun-dependent regulation of macrophage inflammatory protein-2 gene expression in response to lipopolysaccharide in RAW 264.7 cells , 2003 .

[46]  P. Hufnagl,et al.  Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1 (PAI-1) promoter regulates TNF alpha -induced PAI-1 expression. , 2003, Blood.

[47]  D. Faulds,et al.  Theophylline. A review of its potential steroid sparing effects in asthma. , 1998, Drugs.

[48]  C. Allis,et al.  Roles of histone acetyltransferases and deacetylases in gene regulation , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[49]  G. Wogan,et al.  Growth and viability of macrophages continuously stimulated to produce nitric oxide. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[50]  G. Decavalas,et al.  Severe Sepsis and Septic Shock , 2018 .

[51]  M. Hyman,et al.  Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalpha. , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  C. Hack,et al.  TAFI and PAI-1 levels in human sepsis. , 2006, Thrombosis research.

[53]  P. Andreasen,et al.  Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis. , 2004, Thrombosis and haemostasis.

[54]  J. Han,et al.  NF-kappaB and c-Jun-dependent regulation of macrophage inflammatory protein-2 gene expression in response to lipopolysaccharide in RAW 264.7 cells. , 2003, Molecular immunology.